| Issue Date | Title | Author(s) |
| 2-Nov-2022 | Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer | Mo, Hongnan; Yan, Xiaoyan; Zhao, Fang; Teng, Yuee; Sun, Xiaoying; Lv, Zheng; Cao, Mengru; Zhao, Jiuda; Song, Guohong; Pan, Bo; Li, Huihui; Zhai, Jingtong; Xu, Binghe; Ma, Fei |
| Aug-2021 | Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators A Phase 2 Randomized Clinical Trial | Fan, Ying; Sun, Tao; Shao, Zhimin; Zhang, Qingyuan; Ouyang, Quchang; Tong, Zhongsheng; Wang, Shusen; Luo, Yang; Teng, Yuee; Wang, Xiaojia; Wang, Shu; Liu, Qiang; Feng, Jifeng; Shen, Kunwei; Song, Yanqiu; Wang, Jiayu; Ma, Fei; Li, Qing; Zhang, Pin; Xu, Binghe |
| Feb-2020 | Everolimus in first-line treatment of advanced premenopausal breast cancer: Results from MIRACLE (everoliMus trIal foR AdvanCed premenopausaL brEast cancer) study | Fan, Ying; Sun, Tao; Shao, Zhimin; Zhang, Qingyuan; Ouyang, Quchang; Tong, Zhongsheng; Wang, Shusen; Luo, Yang; Teng, Yuee; Wang, Xiaojia; Wang, Shu; Liu, Qiang; Feng, Jifeng; Shen, Kunwei; Song, Yanqiu; Wang, Jiayu; Ma, Fei; Li, Qing; Zhang, Pin; Xu, Binghe |
| 2015 | National consensus in China on diagnosis and treatment of patients with advanced breast cancer | Xu, Binghe; Hu, Xichun; Jiang, Zefei; Li, Huiping; Chen, Jiayi; Cui, Shude; Li, Qing; Liao, Ning; Liu, Donggeng; Liu, Jian; Lu, Jinsong; Shen, Kunwei; Sun, Tao; Teng, Yuee; Tong, Zhongsheng; Wang, Shulian; Wang, Xiang; Wang, Xiaojia; Wang, Yongsheng; Wu, Jiong; Yuan, Peng; Zhang, Pin; Zhang, Qingyuan; Zheng, Hong; Pang, Da; Ren, Guosheng; Shao, Zhimin; Shen, Zhenzhou; Song, Erwei; Song, Santai |
| 2024 | Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial | Jiang, Zefei; Ouyang, Quchang; Sun, Tao; Zhang, Qingyuan; Teng, Yuee; Cui, Jiuwei; Wang, Haibo; Yin, Yongmei; Wang, Xiaojia; Zhou, Xin; Wang, Yongsheng; Sun, Gang; Wang, Jingfen; Zhang, Lili; Yang, Jin; Qian, Jun; Yan, Min; Liu, Xinlan; Yi, Tienan; Cheng, Ying; Li, Man; Zang, Aimin; Wang, Shusen; Wang, Chuan; Wu, Xinhong; Cheng, Jing; Li, Hui; Lin, Ying; Geng, Cuizhi; Gu, Kangsheng; Xie, Chunwei; Xiong, Huihua; Wu, Xiaohong; Yang, Junlan; Li, Qingshan; Chen, Yiding; Li, Fanfan; Zhang, Anqin; Zhang, Yongqiang; Wu, Yudong; Nie, Jianyun; Liu, Qiang; Wang, Kun; Mo, Xueli; Chen, Lilin; Pan, Yueyin; Fu, Peifen; Zhang, Helong; Pang, Danmei; Sheng, Yuan; Han, Yunwei; Wang, Hongxia; Cang, Shundong; Luo, Xianming; Yu, Wenbo; Deng, Rong; Yang, Chaoqiang; Keegan, Patricia |
| 2017 | Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial | Zhang, Pin; Sun, Tao; Zhang, Qingyuan; Yuan, Zhongyu; Jiang, Zefei; Wang, Xiao Jia; Cui, Shude; Teng, Yuee; Hu, Xi-Chun; Yang, Junlan; Pan, Hongming; Tong, Zhongsheng; Li, Huiping; Yao, Qiang; Wang, Yongsheng; Yin, Yongmei; Sun, Ping; Zheng, Hong; Cheng, Jing; Lu, Jinsong; Zhang, Baochun; Geng, Cuizhi; Liu, Jian; Peng, Roujun; Yan, Min; Zhang, Shaohua; Huang, Jian; Tang, Li; Qiu, Rongguo; Xu, Binghe |
